S. Nitayaphan

S. Nitayaphan, J. McNeil, C. Khamboonruang, 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HIV Risk Behavior Patterns Among Young Thai Men

S. Nitayaphan, R. Jenkins, C. Mason, 1999, AIDS and Behavior.

Recruiting Volunteers for a Multisite Phase I/II HIV Preventive Vaccine Trial in Thailand

P. Pitisuttithum, S. Nitayaphan, J. Chiu, 2002, Journal of acquired immune deficiency syndromes.

Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.

S. Nitayaphan, J. Chiu, C. Khamboonruang, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Foundations for a Phase III human immunodeficiency virus vaccine trial: A decade of Thai-U.S. Army collaborative research.

S. Nitayaphan, A. Brown, 2004, Military medicine.

Declining prevalence of HIV‐1 infection in young Thai men

J. Carr, S. Nitayaphan, J. McNeil, 1995, AIDS.

Incidence of HIV‐1 Infection Among Young Men in Thailand

J. Carr, S. Nitayaphan, J. McNeil, 1994, Journal of acquired immune deficiency syndromes.

Longitudinal Analysis of Peripheral and Colonic CD161+ CD4+ T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation

J. Ananworanich, M. Robb, S. Nitayaphan, 2020, Viruses.

Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand.

J. Carr, M. Robb, D. Birx, 2000, AIDS research and human retroviruses.

Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses

Allan C. deCamp, Jerome H. Kim, J. Mullins, 2014, EBioMedicine.

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Allan C. deCamp, Jerome H. Kim, D. Montefiori, 2017, PloS one.

Detection of the Impairment of CD80 Expression on Circulating Monocytes in HIV‐Infected Thai Children

S. Nitayaphan, S. Ubol, S. Kitthawee, 2004, Microbiology and immunology.

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

Jerome H. Kim, H. Liao, B. Haynes, 2013, Proceedings of the National Academy of Sciences.

HIV epidemic in Asia: optimizing and expanding vaccine development

S. Nitayaphan, J. Excler, R. O'Connell, 2012, Expert review of vaccines.

Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1

D. Douek, P. Gilbert, S. Rerks-Ngarm, 2021, eLife.

Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as the primary mechanism of vaccine-induced protection against HIV-1

D. Douek, P. Gilbert, S. Rerks-Ngarm, 2021, bioRxiv.

Clinical signs and symptoms associated with acute HIV infection from an intensely monitored cohort on 2 continents

Jerome H. Kim, M. Robb, S. Nitayaphan, 2022, Medicine.

The Armed Forces Research Institute of Medical Sciences: five decades of collaborative medical research.

S. Nitayaphan, A. Brown, 2011, The Southeast Asian journal of tropical medicine and public health.

Localization of a neutralization site of Theiler's murine encephalomyelitis viruses

S. Nitayaphan, R. Roos, M. Tóth, 1985, Journal of virology.

Factors influencing estimates of HIV-1 infection timing using BEAST

Lydia Bonar, Morgane Rolland, Merlin L. Robb, 2021, PLoS Comput. Biol..

Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection

Jerome H. Kim, M. Betts, S. Peel, 2016, Journal of Virology.

Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.

Jerome H. Kim, C. Andrews, M. Robb, 2013, The Journal of infectious diseases.

Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.

D. Birx, S. Nitayaphan, M. de Souza, 2003, AIDS research and human retroviruses.

Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial

Allan C. deCamp, Jerome H. Kim, D. Montefiori, 2017, The Journal of infectious diseases.

RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection

Jerome H. Kim, J. Mullins, Hongjun Bai, 2021, Virus evolution.

Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Resistance Is Associated with the Syncytium-Inducing Phenotype and Lower CD4 Cell Counts in Subtype CRF01_AE-Infected Patients

M. Robb, D. Birx, S. Nitayaphan, 2003, Journal of Virology.

Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial

Raphael Gottardo, Tomer Hertz, Sergei L. Kosakovsky Pond, 2015, PLoS Comput. Biol..

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders

Jerome H. Kim, J. Mullins, S. Self, 2015, Nature Medicine.

Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection

Jerome H. Kim, N. Frahm, M. Robb, 2018, PLoS pathogens.

Adenovirus-based HIV-1 vaccine candidates tested in efficacy trials elicit CD8+ T cells with limited breadth of HIV-1 inhibition

S. Nitayaphan, M. de Souza, P. Hayes, 2016, AIDS.

Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais.

D. Birx, S. Nitayaphan, D. Mann, 1998, The Journal of infectious diseases.

Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection

B. Haynes, A. McMichael, M. Betts, 2016, PLoS pathogens.

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.

Jerome H. Kim, S. Peel, L. Jagodzinski, 2016, The New England journal of medicine.

Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection

J. Ananworanich, M. Robb, S. Nitayaphan, 2020, Nature Communications.

Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection

J. Ananworanich, M. Robb, S. Nitayaphan, 2020, Nature Communications.

A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand.

J. Carr, M. Robb, D. Birx, 2003, AIDS research and human retroviruses.

Global variability of the human IgG glycome

C. Gieger, T. Spector, P. McKeigue, 2019, bioRxiv.

HIV-1 infections with multiple founders associate with the development of neutralization breadth

Bethany L. Dearlove, Hongjun Bai, E. Sanders-Buell, 2022, PLoS pathogens.

Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth

Hongjun Bai, E. Sanders-Buell, M. Robb, 2021, Journal of virology.

Machine Learning Methods Enable Predictive Modeling of Antibody Feature:Function Relationships in RV144 Vaccinees

Chris Bailey-Kellogg, Jaranit Kaewkungwal, Todd J. Suscovich, 2015, PLoS Comput. Biol..

Infectious Virion Capture by HIV-1 gp120-Specific IgG from RV144 Vaccinees

Jerome H. Kim, H. Liao, J. Kappes, 2013, Journal of Virology.

Virion Capture by HIV-1 gp 120-Specific IgG from RV 144 Vaccinees

Jerome H. Kim, H. Liao, J. Kappes, 2013 .

Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection

Gary J. Nabel, Youyi Fong, Peter B. Gilbert, 2014, PloS one.

The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

Jerome H. Kim, B. Korber, B. Haynes, 2012, AIDS research and human retroviruses.

Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family

Jerome H. Kim, X. Chen, H. Liao, 2012, Journal of Virology.

Quantification of HIV-1 RNA load by one-tube-one-step RT PCR and real time PCR assay with TaqMan probe.

S. Nitayaphan, W. Chantratita, A. Kerdpanich, 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.

D. Birx, P. Pitisuttithum, S. Nitayaphan, 2005, Vaccine.

Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial

Raphael Gottardo, Tomer Hertz, John Sidney, 2014, Journal of Virology.

Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism

Jerome H. Kim, D. Montefiori, M. Robb, 2018, Journal of Virology.

HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial

Jerome H. Kim, C. Andrews, M. Robb, 2014, Immunogenetics.

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2

Tomer Hertz, Peter D. Kwong, Hasan Ahmed, 2012, Nature.

Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.

Jerome H. Kim, H. Liao, B. Haynes, 2014, The Journal of infectious diseases.

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.

Jerome H. Kim, P. Pitisuttithum, S. Nitayaphan, 2012, Vaccine.

Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques.

Jerome H. Kim, H. Liao, Laura L. Sutherland, 2016, JCI insight.

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition

Allan C. deCamp, Jerome H. Kim, S. Zolla-Pazner, 2015, Science Translational Medicine.

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope

Jaranit Kaewkungwal, Nelson L Michael, Supachai Rerks-Ngarm, 2012, The Journal of Immunology.

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

Jaranit Kaewkungwal, Joseph Chiu, Nelson L Michael, 2012, The Lancet. Infectious diseases.

Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines

Jerome H. Kim, C. Bailey-Kellogg, C. Andrews, 2014, Science Translational Medicine.

HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.

S. Rerks-Ngarm, S. Nitayaphan, J. Kaewkungwal, 2015, Tissue antigens.

CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants

Jerome H. Kim, J. Mullins, E. Sanders-Buell, 2014, PloS one.

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

Hasan Ahmed, Hongmei Gao, Jaranit Kaewkungwal, 2012, The Journal of infectious diseases.

A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination

S. Kent, S. Rerks-Ngarm, P. Pitisuttithum, 2021, Cell reports. Medicine.

DTH responsiveness of HIV-infected Thai adults.

D. Birx, S. Nitayaphan, A. Brown, 2000, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Aggregate complexes of HIV-1 induced by multimeric antibodies

Jerome H. Kim, B. Haynes, D. Montefiori, 2014, Retrovirology.

Willingness to participate in HIV-1 vaccine trials among young Thai men

S. Nitayaphan, R. Jenkins, C. Mason, 2000, Sexually transmitted infections.

CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants

Lindsay N. Carpp, Jerome H. Kim, H. Liao, 2014, PloS one.

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

Jerome H. Kim, M. Robb, S. Rerks-Ngarm, 2017, AIDS Research and Human Retroviruses.

Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand

M. Robb, P. Pitisuttithum, S. Nitayaphan, 2021, EClinicalMedicine.

HIV Epidemic among Young Thai Men, 1991–2000

S. Nitayaphan, S. Sangkharomya, N. Sirisopana, 2003, Emerging infectious diseases.

Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men.

S. Nitayaphan, C. Mason, L. Markowitz, 1998, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology.

Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping.

J. Carr, M. Robb, D. Birx, 2006, AIDS research and human retroviruses.

Heterosexually acquired CRF01_AE/B recombinant HIV type 1 found in Thailand.

J. Carr, D. Birx, F. McCutchan, 2002, AIDS research and human retroviruses.

First CRF01_AE/B recombinant of HIV-1 is found in Thailand.

J. Carr, E. Sanders-Buell, D. Birx, 2001, AIDS.

Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand

Jerome H. Kim, V. Valcour, K. Williams, 2008, Journal of Neuroimmunology.

The development of HIV research laboratories in the Royal Thai Army Medical Department.

S. Nitayaphan, M. de Souza, J. Gaywee, 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Issues in women's participation in a phase III community HIV vaccine trial in Thailand.

Jerome H. Kim, S. Rerks-Ngarm, P. Pitisuttithum, 2013, AIDS research and human retroviruses.

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor

Jerome H. Kim, S. Zolla-Pazner, S. Rerks-Ngarm, 2015, PloS one.

Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial

Jerome H. Kim, T. Kepler, H. Liao, 2017, PLoS pathogens.

HIV‐specific antibody‐dependent phagocytosis matures during HIV infection

Jerome H. Kim, R. Center, S. Kent, 2014, Immunology and cell biology.

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

James Y. Dai, Jerome H. Kim, H. Liao, 2014, The Journal of clinical investigation.

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees

G. Alter, S. Rerks-Ngarm, P. Pitisuttithum, 2020, JCI insight.

RV144 HIV-1 vaccination impacts post-infection antibody responses

Jerome H. Kim, E. Sanders-Buell, M. Robb, 2020, PLoS pathogens.

Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response.

Jerome H. Kim, M. Robb, G. Alter, 2020, JCI insight.

Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial

Allan C. deCamp, Jerome H. Kim, B. Korber, 2013, PloS one.

Vaccine-Induced HIV-1 Envelope gp120 Constant Region 1-Specific Antibodies Expose a CD4-Inducible Epitope and Block the Interaction of HIV-1 gp140 with Galactosylceramide

Jerome H. Kim, H. Liao, B. Haynes, 2014, Journal of Virology.

COMPASS identifies T-cell subsets correlated with clinical outcomes

Greg Finak, Raphael Gottardo, Jaranit Kaewkungwal, 2015, Nature Biotechnology.

HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities

Jerome H. Kim, H. Liao, B. Haynes, 2014, Journal of Virology.

HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions.

Jerome H. Kim, P. Zhang, E. Go, 2020, JCI insight.

Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency

Jerome H. Kim, T. Kepler, B. Haynes, 2019, Journal of Virology.

A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infection

Jerome H. Kim, Yufei Wang, T. Whittall, 2017, Scientific Reports.

Preventive HIV vaccine development in Thailand.

S. Nitayaphan, A. Brown, 1998, AIDS.

ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone

Jerome H. Kim, M. Robb, S. Nitayaphan, 2023, JCI insight.

Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion

Jerome H. Kim, Haiyan Chen, H. Liao, 2012, Journal of Virology.

Region of HIV-1 Envelope Preferentially Target Epitopes within the V2 Regimen Induces T Cell Responses That The Thai Phase III Trial (RV144) Vaccine

S. Rerks-Ngarm, P. Pitisuttithum, S. Nitayaphan, 2012 .

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais.

J. Mascola, D. Birx, S. Nitayaphan, 2000 .

Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee☆

Jerome H. Kim, T. Kepler, H. Liao, 2015, EBioMedicine.

Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response

Rachel L. Spreng, Lindsay C. Dahora, Jerome H. Kim, 2023, PLoS pathogens.

Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2.

G. Chang, S. Nitayaphan, D. Trent, 1990, Virology.

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

Punnee Pitisuttithum, Sorachai Nitayaphan, Victoria Polonis, 2004, The Journal of infectious diseases.

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

Jerome H. Kim, C. Andrews, M. Robb, 2015, AIDS research and human retroviruses.

Flow cytometric detection of intracellular cytokines in peripheral blood of HIV-1 infected Thai children.

S. Nitayaphan, S. Ubol, S. Akapirat, 2001, Asian Pacific journal of allergy and immunology.

Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses

S. Nitayaphan, R. Roos, M. Tóth, 1985, Journal of virology.

Galactosylceramide the Interaction of HIV-1 gp 140 with Expose a CD 4-Inducible Epitope and Block Constant Region 1-Specific Antibodies Vaccine-Induced HIV-1 Envelope gp

Jerome H. Kim, H. Liao, B. Haynes, 2014 .

Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

Jerome H. Kim, D. Birx, P. Pitisuttithum, 2003, The Journal of infectious diseases.

Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine

Jerome H. Kim, R. Gottardo, R. Koup, 2019, Nature Communications.

An isoelectric focusing overlay study of the humoral immune response in Theiler's virus demyelinating disease

S. Nitayaphan, R. Roos, E. A. Nalefski, 1987, Journal of Neuroimmunology.

Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand

Jerome H. Kim, D. Stablein, M. Robb, 2015, PloS one.

A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences.

J. Mascola, D. Birx, S. Nitayaphan, 2000, Vaccine.

Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses

Jerome H. Kim, E. Sanders-Buell, M. Robb, 2021, PLoS pathogens.

HIV viral load in Thai men and women with subtype E infections.

S. Nitayaphan, M. de Souza, A. Brown, 2001, Journal of acquired immune deficiency syndromes.

Cytokine profiles in HIV-1 subtype CRF01_AE infected individuals with different rates of diseases progression: a multiplex immunoassay.

S. Nitayaphan, N. Sirisopana, R. Sutthent, 2012, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses.

G. Parks, S. Nitayaphan, R. Roos, 1986, Intervirology.

Cryptic Multiple HIV-1 Infection Revealed by Early, Frequent, and Deep Sampling during Acute Infection

Phuc T. Pham, Jerome H. Kim, B. Korber, 2014 .

Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial.

Jerome H. Kim, M. Robb, P. Pitisuttithum, 2020, The lancet. HIV.

Impact of early ART initiation on performance of cross sectional incidence assays.

O. Laeyendecker, M. Robb, S. Nitayaphan, 2020, AIDS research and human retroviruses.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

M. Robb, D. Birx, S. Rerks-Ngarm, 2009, The New England journal of medicine.

Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability

G. Ferrari, S. Nitayaphan, S. Gurunathan, 2023, AIDS.